Novo Nordisk

NOVOEIGHT

Manufacturer:

Novo Nordisk

Novoeight HCPCS:

J7182

HCPCS Code Descriptor:

Injection, factor viii, (antihemophilic factor, recombinant), (novoeight), per iu

Category:

J Code

Novoeight NDCs:

00169-7815-01, 00169-7850-01, 00169-7810-01, 00169-7820-01, 00169-7830-01, 00169-7825-01

Primary Type:

Hematology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Novoeight CPT Codes:

Potential CPT administration codes for Novoeight can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Novoeight:

NOVOEIGHT is a Hematology drug manufactured by Novo Nordisk and administered via the Intravenous route of administration. The J Code: J7182 is aligned to the drug NOVOEIGHT.

ACCESS PRICING AND MORE BY REGISTERING

J7182 Added Date:

January 1, 2015

J7182 Effective Date:

January 1, 2017

J7182 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Novoeight billing and coding information.
Novoeight patient assistance information can be found through Novo Nordisk’s NovoCare at the URL: https://www.mynovosecure.com/resources.html
NOVOEIGHT prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for NOVOEIGHT. Please check back in a few weeks.